Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Nguyen

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Orally available designed miniproteins inhibit enterotoxigenic <i>Bacteroides fragilis</i> pathology by blocking toxin receptor bindingPooja Srinivas, Victor Adebomi, Susan M Markiewicz, et al.
Brachytherapy|October 17, 2025
Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancerHayeon Kim, Wei Deng, Dimitriy Zamarin, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Nature Communications|March 28, 2026
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Controlling metal-carbonate phase, form, and function through de novo protein designPaul S Kwon, Xinqi Li, Le Tracy Yu, et al.
Science (New York, N.Y.)|August 17, 2023
Design of stimulus-responsive two-state hinge proteinsFlorian Praetorius, Philip J Y Leung, Maxx H Tessmer, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinasesStephen Claridge, Franck Raeppel, Marie-Claude Granger, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Orally available designed miniproteins inhibit enterotoxigenic <i>Bacteroides fragilis</i> pathology by blocking toxin receptor bindingPooja Srinivas, Victor Adebomi, Susan M Markiewicz, et al.
Brachytherapy|October 17, 2025
Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancerHayeon Kim, Wei Deng, Dimitriy Zamarin, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Nature Communications|March 28, 2026
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Controlling metal-carbonate phase, form, and function through de novo protein designPaul S Kwon, Xinqi Li, Le Tracy Yu, et al.
Science (New York, N.Y.)|August 17, 2023
Design of stimulus-responsive two-state hinge proteinsFlorian Praetorius, Philip J Y Leung, Maxx H Tessmer, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinasesStephen Claridge, Franck Raeppel, Marie-Claude Granger, et al.
Pageof 7